Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease (Q38618659)

4 September 2017

1 reference

title

Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

4 September 2017

0 references

author name string

Järnerot G

series ordinal

1

1 reference

4 September 2017

1 January 1989

1 reference

4 September 2017

1 reference

4 September 2017

37

1 reference

4 September 2017

1

1 reference

4 September 2017

73-86

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198937010-00005

4 September 2017

0 references

cites work

Transit of pharmaceutical dosage forms through the small intestine

1 reference

12 December 2020

Kinetics of 5-aminosalicylic acid after jejunal instillation in man.

1 reference

12 December 2020

An oral preparation to release drugs in the human colon

1 reference

12 December 2020

Treatment of Crohn's disease with peroral 5-aminosalicylic acid

1 reference

12 December 2020

Nephrotoxic lesions from 5-aminosalicylic Acid.

1 reference

12 December 2020

Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas

1 reference

12 December 2020

The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis

1 reference

12 December 2020

Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis. A randomized, double-blind multicenter trial. Danish 5-ASA Group

1 reference

12 December 2020

Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides

1 reference

12 December 2020

Induction of and adaptation to olsalazine induced intestinal volume load.

1 reference

12 December 2020

Male infertility due to sulphasalazine

1 reference

12 December 2020

Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse

1 reference

12 December 2020

Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide

1 reference

12 December 2020

Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract

1 reference

12 December 2020

Salicylazosulfapyridine in clinical practice

1 reference

12 December 2020

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

1 reference

12 December 2020

Spontaneous formation of immunogenic conjugates by 5-aminosalicylic acid--a biotransformation product of salicylazosulfapyridine

1 reference

12 December 2020

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020

Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion

1 reference

12 December 2020

Evaluation of an enteric-coated delayed-release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease

1 reference

12 December 2020

Distribution studies of salicylazosulfapyridine and its metabolites

1 reference

12 December 2020

Reversible Toxic Effect of Salicylazosulf Apyridine on Semen Quality

1 reference

12 December 2020

Acute ulcerative colitis--a rare complication of sulfasalazine therapy

1 reference

12 December 2020

5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial

1 reference

12 December 2020

Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis

1 reference

12 December 2020

Influence of olsalazine on gastrointestinal transit in ulcerative colitis

1 reference

12 December 2020

Topical treatment of distal ulcerative colitis with 4-amino-salicylic acid enemas

1 reference

12 December 2020

Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution

1 reference

12 December 2020

Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis

1 reference

12 December 2020

5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans

1 reference

12 December 2020

Clinical tolerance of olsalazine.

1 reference

12 December 2020

Intensive intravenous treatment of ulcerative colitis

1 reference

12 December 2020

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

12 December 2020

Olsalazine does not increase the bile acid losses in subjects with a permanent ileostomy

1 reference

12 December 2020

Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial

1 reference

12 December 2020

Bloody diarrhea—a new complication of sulfasalazine

1 reference

12 December 2020

A new slow-release form of 5-aminosalicylic acid for the oral treatment of inflammatory bowel disease. Biopharmaceutic and clinical pharmacokinetic characteristics

1 reference

12 December 2020

Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis

1 reference

12 December 2020

Nephrotic syndrome after treatment with 5-aminosalicylic acid

1 reference

12 December 2020

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

1 reference

12 December 2020

Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis

1 reference

12 December 2020

Olsalazine in active ulcerative colitis

1 reference

12 December 2020

Sulphasalazine in rheumatoid arthritis

1 reference

12 December 2020

Which component of sulphasalazine is active in rheumatoid arthritis?

1 reference

12 December 2020

Effects of olsalazine in the jejunum of the rat.

1 reference

12 December 2020

Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis

1 reference

12 December 2020

Absorption, metabolism, and excretion of salicylazosulfapyridine in man

1 reference

12 December 2020

Proctocolitis induced by salicylate and associated with asthma and recurrent nasal polyps

1 reference

12 December 2020

Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth

1 reference

12 December 2020

Effect of a slow-release 5'-aminosalicylic acid preparation on disease activity in Crohn's disease

1 reference

12 December 2020

Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis

1 reference

12 December 2020

5-Aminosalicylic acid in patients with an ileo-rectal anastomosis. A comparison of the fate of sulfasalazine and Pentasa

1 reference

12 December 2020

Renal function was not impaired by treatment with 5-aminosalicylic acid in rats and man

1 reference

12 December 2020

Olsalazine in the treatment of active ulcerative colitis: a placebo controlled clinical trial and assessment of drug disposition

1 reference

12 December 2020

Exacerbation of diarrhoea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis

1 reference

12 December 2020

Sulfasalazine-Induced Exacerbation of Ulcerative Colitis

1 reference

12 December 2020

Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine

1 reference

12 December 2020

Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties

1 reference

12 December 2020

Azodisalicylate (azodisal sodium) causes intestinal secretion. Comparative study of the effect of azodisalicylate, sulfasalazine, 5-aminosalicylic acid and sulfapyridine on the water and electrolyte transfer and the morphology of the rat ileum and c

1 reference

12 December 2020

A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis

1 reference

12 December 2020

Absorption and excretion of azodisal sodium and its metabolites in man after rectal administration of a single 2-g dose

1 reference

12 December 2020

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020

Salicylate other than 5-aminosalicylic acid ineffective in ulcerative colitis

1 reference

12 December 2020

Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds

1 reference

12 December 2020

The influence of metabolic variation on analgesic nephrotoxicity. Experiments with the Gunn rat.

1 reference

12 December 2020

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis

1 reference

12 December 2020

Clinical Pharmacokinetics of Sulphasalazine

1 reference

12 December 2020

Disposition of disodium azodisalicylate in healthy subjects. A possible new drug for inflammatory bowel disease

1 reference

12 December 2020

Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 alpha in subjects with a permanent ileostomy

1 reference

12 December 2020

5-Aminosalicylic acid enemas in patients with active ulcerative colitis. Influence of acidity on the kinetic pattern

1 reference

12 December 2020

Sulfasalazine-induced colitis complicating idiopathic ulcerative colitis

1 reference

12 December 2020

Long-term treatment with olsalazine for ulcerative colitis: safety and relapse prevention: a follow-up study

1 reference

12 December 2020

Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis

1 reference

12 December 2020

Absorption and excretion of a single 1-g dose of azodisal sodium in subjects with ileostomy

1 reference

12 December 2020

4-Aminosalicylic acid retention enemas in treatment of distal colitis.

1 reference

12 December 2020

Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients

1 reference

12 December 2020

Salicylate induced exacerbation of ulcerative colitis

1 reference

12 December 2020

Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid

1 reference

12 December 2020

5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results

1 reference

12 December 2020

Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis

1 reference

12 December 2020

10.2165/00003495-198937010-00005

Identifiers

DOI

1 reference

PubMed ID

2651087

Dimensions Publication ID

4 September 2017

0 references

1 reference

PubMed ID

2651087